Back to medications
Medication monograph

mirikizumab

Interleukin InhibitorsImmunomodulatorsInterleukin-23 Antagonist

Brands & formulations

Family members

OMVOH

Marketed
100 MGSUBCUTANEOUSSOLUTION[ "mirikizumab" ]
Product monograph

OMVOH

Marketed
100 MGSUBCUTANEOUSSOLUTION[ "mirikizumab" ]
Product monograph

OMVOH

Marketed
20 MGINTRAVENOUSSOLUTION[ "mirikizumab" ]
Product monograph

Classification

Chemical class
Interleukin Inhibitors
Clinical class
Immunomodulators
Banks class
Interleukin-23 Antagonist